Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
Article first published online: 21 JAN 2005
Copyright © 2005 Wiley-Liss, Inc.
Volume 64, Issue 1, pages 92–100, 15 June 2005
How to Cite
Ishiguro, H., Nakaigawa, N., Miyoshi, Y., Fujinami, K., Kubota, Y. and Uemura, H. (2005), Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate, 64: 92–100. doi: 10.1002/pros.20219
- Issue published online: 13 MAY 2005
- Article first published online: 21 JAN 2005
- Manuscript Accepted: 19 OCT 2004
- Manuscript Received: 25 JUL 2004
- Ministry of Education, Science, and Culture of Japan
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.